Trending Now
BUSINESS
U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01...
Cellectis a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced that the MELANI-01 trial has been placed...
MEDICAL DEVICES
MANUFACTURING
Thermo Fisher Scientific Acquires MTI-GlobalStem
Thermo Fisher Scientific, the world leader in serving science, today announced it has signed a purchase agreement to acquire MTI-GlobalStem, a privately-held company that...
DON'T MISS
JOURNAL SPOTLIGHT
‘Decorated’ Stem Cells Could Offer Targeted Heart Repair
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury – and...